von Borstel & Associates’s Amgen AMGN Stock Holding History

von Borstel & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-914	Closed	-$295K	–	50
2025 Q3	$295K	Buy	+914	New	+$265K	0.05%	126

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

von Borstel & Associates's AMGN Position: Q4 2025 in Review

von Borstel & Associates sold out of Amgen (AMGN) in Q4 2025, closing a stake of 914 shares — an estimated $295K sold.

von Borstel & Associates first reported a position in AMGN in Q3 2025 and held it in 1 quarter. The position peaked at $295K in Q3 2025. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

von Borstel & Associates reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
von Borstel & Associates sold 914 Amgen shares in Q4 2025, an estimated $295K.
von Borstel & Associates first reported a position in Amgen in Q3 2025 and held it in 1 quarter.
von Borstel & Associates's Amgen position peaked at $295K in Q3 2025.
3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on von Borstel & Associates's 13F filing for Q4 2025, filed 12 Feb 2026.